[Federal Register Volume 65, Number 45 (Tuesday, March 7, 2000)]
[Notices]
[Page 12014]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-5466]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 99N-2875]


Agency Information Collection Activities; Announcement of OMB 
Approval; Blood Establishment Registration and Product Listing--Form 
FDA 2830

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Blood Establishment Registration 
and Product Listing--Form FDA 2830'' has been approved by the Office of 
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: JonnaLynn P. Capezzuto, Office of 
Information Resources Management (HFA-250), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.

SUPPLEMENTARY INFORMATION: In the Federal Register of December 20, 1999 
(64 FR 71144), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0052. 
The approval expires on February 28, 2003. A copy of the supporting 
statement for this information collection is available on the Internet 
at http://www.fda.gov/ohrms/dockets.

    Dated: February 29, 2000.
William K. Hubbard,
Senior Associate Commissioner for Policy, Planning, and Legislation.
[FR Doc. 00-5466 Filed 3-6-00; 8:45 am]
BILLING CODE 4160-01-F